DUBLIN--(BUSINESS WIRE)--Research and Markets has announced the addition of the "World Intravenous Access Devices Market - Opportunities and Forecasts, 2014 - 2022" report to their offering.
Intravenous Access Devices are a prominent sector of the Healthcare industry. These devices are used by physicians for treating patients as well as testing blood after withdrawing it via intravenous route. Intravenous access devices are used for administering all the classes of drugs like antibiotics, antipyretics and analgesics. Rising incidences of different diseases such as tuberculosis, cancer and others are the key drivers of this market. Moreover, urbanization and growing geriatric population all over the world boost the growth of the Intravenous (IV) Access Devices market.
Growing development of new vaccines and use of advanced technology to design new products are another driver for the market. However, lenient government regulations for approving Intravenous (IV) insulin infusion pumps and risks associated with using needles are the major restraints of this market. Furthermore, rise in the number of patients and increased disposable incomes among emerging countries are the key opportunities for this market.
On the basis of its types, an intravenous access devices market is segmented into Intravenous Catheters, Intravenous Infusion Pumps and Intravenous Needles.
- The market is segmented by type of product, which would enable a deeper understanding of the scope for this market.
- Geographic segmentation would enable stakeholders to make region specific plans for growth in untapped regions.
- Analysis provides an overview of the market like its drivers, opportunities and restraints. Moreover, Porter's Five Force Model and SWOT analysis are strategically discussed for the global intravenous access devices market.
- The analysis assists in understanding the strategies adopted by the companies for the growth of the intravenous access devices market.
- Becton Dickinson & Company
- B. Braun Melsungen AG
- Teleflex Incorporated
- Medtronic, Inc.
- Smiths Medical
- Hospira, Inc.
- Covidien Plc
- Fresenius Medical Care AG & Co.
- CareFusion Corporation
For more information about this report visit http://www.researchandmarkets.com/research/dmzq8n/world_intravenous